NeuroPace Continues to Strengthen Management Team
Neuropace, Inc. (NPCE)
Company Research
Source: GlobeNewswire
MOUNTAIN VIEW, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced the appointment of Amy Treadwell as its new Vice President of Human Resources, effective immediately. “We are excited to have Amy join the team and help us continue to build an engaged, high-performing culture that supports our growth,” said Joel Becker, Chief Executive Officer of NeuroPace. “We are at an important point in our growth with a number of significant commercial, operating, and technological opportunities in front of us. We believe Amy’s appointment, along with the recent appointments of Brett Wingeier as Vice President of Research and Development and Katie Keller as Vice President of Marketing, helps position us to take full advantage of these opportunities and execute our strategy of increasing access, adoption, and utilization of RNS therapy.” “I am excited to join NeuroPac
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- What Makes NeuroPace (NPCE) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade [Yahoo! Finance]Yahoo! Finance
- NeuroPace Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NASDAQ: NPCE) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $13.00. They now have an "overweight" rating on the stock.MarketBeat
- NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 11/12/24 - Beat
NPCE
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/12/24 - Form 10-Q
- NPCE's page on the SEC website